CRISPR Therapeutics AG (CRSP-Q)
NASDAQ:CRSP
37.88
0.11
(0.29%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
Related posts
Top Biotech and Pharma Stocks to Bet on Cancer Cure & ControlBiotechnology, Gene-editing and Medical Research Stocks to Buy in 2019Top Stocks with Groundbreaking Potential in the DNS Manipulation and Gene-Editing MarketsThis summary was created by AI, based on 3 opinions in the last 12 months.
CRISPR Therapeutics AG (CRSP-Q) has garnered attention from experts in the field, particularly for its innovative gene-editing technology, which is frequently referenced in scientific literature. Despite its promising technology, the company has struggled to maintain profitability, leading to a decline in stock value compared to previous years. Some analysts express optimism and suggest investors consider purchasing shares at current prices, particularly if the stock dips further. However, those unfamiliar with the intricacies of gene technology may be hesitant to invest. Overall, there is a belief in the company's potential, but caution is advised due to its financial performance.
- «
- ‹
- 1
- ›
- »
CRISPR Therapeutics AG(CRSP-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 2
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 2
CRISPR Therapeutics AG(CRSP-Q) Frequently Asked Questions
What is CRISPR Therapeutics AG stock symbol?
CRISPR Therapeutics AG is a American stock, trading under the symbol CRSP-Q on the NASDAQ (CRSP). It is usually referred to as NASDAQ:CRSP or CRSP-Q
Is CRISPR Therapeutics AG a buy or a sell?
In the last year, 2 stock analysts published opinions about CRSP-Q. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for CRISPR Therapeutics AG.
Is CRISPR Therapeutics AG a good investment or a top pick?
CRISPR Therapeutics AG was recommended as a Top Pick by on . Read the latest stock experts ratings for CRISPR Therapeutics AG.
Why is CRISPR Therapeutics AG stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is CRISPR Therapeutics AG worth watching?
2 stock analysts on Stockchase covered CRISPR Therapeutics AG In the last year. It is a trending stock that is worth watching.
What is CRISPR Therapeutics AG stock price?
On 2025-04-18, CRISPR Therapeutics AG (CRSP-Q) stock closed at a price of $37.88.
He sees this company mentioned in many science papers, but the stock has been a tough own. Overall, he likes it. Buy some now and more if it goes lower. How can this company keep losing money?